Literature DB >> 32504046

Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.

Nikolai Eroshenko1, Taylor Gill1, Marianna K Keaveney1, George M Church2,3, Jose M Trevejo4, Hannu Rajaniemi5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32504046     DOI： 10.1038/s41587-020-0577-1

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  57 in total

1.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.

Authors:  Susana V Bardina; Paul Bunduc; Shashank Tripathi; James Duehr; Justin J Frere; Julia A Brown; Raffael Nachbagauer; Gregory A Foster; David Krysztof; Domenico Tortorella; Susan L Stramer; Adolfo García-Sastre; Florian Krammer; Jean K Lim
Journal:  Science       Date:  2017-03-30       Impact factor: 47.728

2.  Immunologic phenomena in the effusive form of feline infectious peritonitis.

Authors:  N C Petersen; J F Boyle
Journal:  Am J Vet Res       Date:  1980-06       Impact factor: 1.156

3.  Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization.

Authors:  H Vennema; R J de Groot; D A Harbour; M Dalderup; T Gruffydd-Jones; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.

Authors:  Natalia A Kuzmina; Patrick Younan; Pavlo Gilchuk; Rodrigo I Santos; Andrew I Flyak; Philipp A Ilinykh; Kai Huang; Ndongala M Lubaki; Palaniappan Ramanathan; James E Crowe; Alexander Bukreyev
Journal:  Cell Rep       Date:  2018-08-14       Impact factor: 9.423

5.  Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.

Authors:  Yun-Chi Chen; Sheng-Yuan Wang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.

Authors:  Catharine M Bosio; M Javad Aman; Case Grogan; Robert Hogan; Gordon Ruthel; Diane Negley; Mansour Mohamadzadeh; Sina Bavari; Alan Schmaljohn
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

7.  Antibody-dependent enhancement of severe dengue disease in humans.

Authors:  Leah C Katzelnick; Lionel Gresh; M Elizabeth Halloran; Juan Carlos Mercado; Guillermina Kuan; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

8.  Is COVID-19 receiving ADE from other coronaviruses?

Authors:  Jason A Tetro
Journal:  Microbes Infect       Date:  2020-02-22       Impact factor: 2.700

Review 9.  Fc receptors in antibody-dependent enhancement of viral infections.

Authors:  Adam Taylor; Suan-Sin Foo; Roberto Bruzzone; Luan Vu Dinh; Nicholas J C King; Suresh Mahalingam
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

10.  Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.

Authors:  Yushun Wan; Jian Shang; Shihui Sun; Wanbo Tai; Jing Chen; Qibin Geng; Lei He; Yuehong Chen; Jianming Wu; Zhengli Shi; Yusen Zhou; Lanying Du; Fang Li
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103
View more
  41 in total

Review 1.  Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.

Authors:  Dhuha H Nawab
Journal:  Hum Vaccin Immunother       Date:  2021-11-29       Impact factor: 3.452

Review 2.  COVID-19 vaccine development: milestones, lessons and prospects.

Authors:  Maochen Li; Han Wang; Lili Tian; Zehan Pang; Qingkun Yang; Tianqi Huang; Junfen Fan; Lihua Song; Yigang Tong; Huahao Fan
Journal:  Signal Transduct Target Ther       Date:  2022-05-03

3.  Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2.

Authors:  Donovan Guttieres; Anthony J Sinskey; Stacy L Springs
Journal:  Antib Ther       Date:  2021-03-20

Review 4.  Glycosylation is a key in SARS-CoV-2 infection.

Authors:  Celso A Reis; Rudolf Tauber; Véronique Blanchard
Journal:  J Mol Med (Berl)       Date:  2021-05-22       Impact factor: 4.599

5.  Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death.

Authors:  Laszlo Szekely; Bela Bozoky; Matyas Bendek; Masih Ostad; Pablo Lavignasse; Lars Haag; Jieyu Wu; Xu Jing; Soham Gupta; Elisa Saccon; Anders Sönnerborg; Yihai Cao; Mikael Björnstedt; Attila Szakos
Journal:  Heliyon       Date:  2021-05-24

Review 6.  Prospects of Neutralizing Nanobodies Against SARS-CoV-2.

Authors:  Fangfang Chen; Zhihong Liu; Fan Jiang
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

Review 7.  Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.

Authors:  Qianqian Zhang; Rong Xiang; Shanshan Huo; Yunjiao Zhou; Shibo Jiang; Qiao Wang; Fei Yu
Journal:  Signal Transduct Target Ther       Date:  2021-06-11

Review 8.  Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?

Authors:  Yongzhi Xi
Journal:  Signal Transduct Target Ther       Date:  2020-09-15

Review 9.  Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.

Authors:  Kumaragurubaran Karthik; Tuticorin Maragatham Alagesan Senthilkumar; Shanmugasundaram Udhayavel; Gopal Dhinakar Raj
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

10.  Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.

Authors:  Wanshen Guo; Kai Duan; Yuntao Zhang; Zhiming Yuan; Yan-Bo Zhang; Zejun Wang; Dongyang Zhao; Huajun Zhang; Zhiqiang Xie; Xinguo Li; Cheng Peng; Wei Zhang; Yunkai Yang; Wei Chen; Xiaoxiao Gao; Wangyang You; Xue-Wei Wang; Zhengli Shi; Yanxia Wang; Xu-Qin Yang; Lianghao Zhang; Lili Huang; Qian Wang; Jia Lu; Yong-Li Yang; Jing Guo; Wei Zhou; Xin Wan; Cong Wu; Wenhui Wang; Jianhui Du; Xuanxuan Nian; Xing-Hang Li; Shihe Huang; Shuo Shen; Shengli Xia; An Pan; Xiaoming Yang
Journal:  EClinicalMedicine       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.